| Phase 4 |
| NCT06927375 |
A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of… |
Thyroid-Associated Ophthalmopathy |
Recruiting |
| Phase 3 |
| NCT07445048 |
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in… |
Head & Neck Squamous Cell Carcinoma |
Recruiting |
| NCT06647563 |
Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck… |
Squamous Cell Carcinoma of Head and Neck |
Not Yet Recruiting |
| NCT07320690 |
De-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell… |
Squamous Cell Carcinoma of the Head and Neck |
Not Yet Recruiting |
| Phase 2/3 |
| NCT06819605 |
Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF… |
Ameloblastoma |
Not Yet Recruiting |
| NCT07535567 |
Postoperative Radiotherapy With Nimotuzumab ± Benmelstobart in Intermediate-Risk Head and… |
Head and Neck Squamous Cell Carcinoma |
Not Yet Recruiting |
| Phase 2 |
| NCT06081673 |
Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients… |
Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT06503276 |
The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib… |
Extranodal Marginal Zone B-cell Lymphoma |
Recruiting |
| NCT06653517 |
Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma |
Ameloblastoma |
Recruiting |
| NCT06470217 |
Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable… |
Locally Advanced Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT06876844 |
Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic… |
Head and Neck Cancer |
Recruiting |
| NCT06935188 |
Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative… |
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT07632339 |
Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and… |
Head and Neck Cancer |
Recruiting |
| NCT07088211 |
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC |
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT07090317 |
Iparomlimab and Tuvonralimab in HNSCC |
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT07662746 |
Efficacy and Safety of Paclitaxel Polymeric Micelles in Patients With… |
Head and Neck Cancer |
Recruiting |
| NCT07029178 |
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis |
Radiation Induced Oral Mucositis |
Recruiting |
| NCT06728631 |
Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL |
Oral Cavity Cancer |
Active, Not Recruiting |
| NCT05586100 |
Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable… |
Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma |
Active, Not Recruiting |
| NCT07353073 |
A Prospective, Single-Arm, Phase II Clinical Study of Neoadjuvant Therapy With… |
Head and Neck Mucosal Melanomas |
Not Yet Recruiting |
| NCT07579598 |
ADC and SBRT for Recurrent/Metastatic Salivary Gland Carcinoma |
Adenoid Cystic Carcinoma of the Head and Neck |
Not Yet Recruiting |
| NCT07728201 |
Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis |
Langerhans Cell Histiocytosis |
Not Yet Recruiting |
| Phase 1/2 |
| NCT07662681 |
Camrelizumab With Famitinib for Patients With Rare Head and Neck Malignancies |
Head and Neck Cancer |
Recruiting |
| Early Phase 1 |
| NCT05883293 |
Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of… |
Pulmonary Fibrosis |
Active, Not Recruiting |
| Not specified |
| NCT05555693 |
Correlation Between Postoperative Cognitive-related Adverse Reactions and Brain… |
POCD - Postoperative Cognitive Dysfunction |
Recruiting |